Our results showed that ddPCR is an alternatively potent method for detection of EGFR T790M mutation in the plasma samples of NSCLC patients with high sensitivity, lower cost, and shorter experimental period. This evidence concerns the gene EGFR and non-small cell lung carcinoma.